Small Molecules Attract Investors As Two Chinese Biotechs Bag $161m

Jiangsu Hengrui subsidiary Reistone and Shanghai Laekna raise a combined $161m for their innovative candidates.

fund raising
Reistone, Shanghai Laekna raise $100m and $61m respectively in latest funding rounds • Source: Alamy

More from China

More from Focus On Asia